Featured Research

from universities, journals, and other organizations

For Some, Sleep Style Serves As Harbinger Of Depression

Date:
April 18, 2001
Source:
University Of Rochester
Summary:
The search for the genetic roots of depression has led scientists to the bedroom, where they’ve discovered that people with a particular type of sleep pattern and a family history of depression are twice as likely to become depressed as relatives who don’t sleep the same way. The link is true even in family members who have no history of the disease themselves and who feel absolutely fine.

The search for the genetic roots of depression has led scientists to the bedroom, where they’ve discovered that people with a particular type of sleep pattern and a family history of depression are twice as likely to become depressed as relatives who don’t sleep the same way. The link is true even in family members who have no history of the disease themselves and who feel absolutely fine.

The findings come from a team led by University of Rochester Medical Center psychologist Donna Giles, Ph.D., who uses sleep as a window to study the origins of depression. Her latest work, part of a study that stretches back to 1985, builds on the link between sleep and depression to try and identify a specific brain chemical that may be at the root of depression for some patients.

Giles and her colleagues have found that the speed with which people fall into dream sleep can indicate people who are more prone to depression. In families where at least one person is depressed, people who enter dream sleep less than 60 minutes after falling asleep are more than twice as likely to become depressed than relatives who enter dream sleep in the more common 90-minute range.

"This is the first physiological marker that predicts the onset of depression even in someone who has never had the illness," says Giles, whose work is funded by the National Institute of Mental Health. "While doctors know that depression in one’s family can make a person more prone to the disorder, understanding the link in detail has been difficult. Right now, doctors can’t predict who will become depressed."

Dream sleep, or rapid-eye-movement (REM) sleep, is the fifth of five stages of sleep that we cycle through several times each night. Our brain activity slows progressively throughout the first four stages, and then suddenly in REM sleep, our brains kick into high gear. "In REM sleep, brain activity looks just as it does when we’re awake, but our muscles are inhibited," says Giles, professor of psychiatry. "It’s also known as paradoxical sleep, because the brain behaves as if we’re awake."

The sleep disturbances that many depressed people have, such as sleeping more than usual or having difficulty falling asleep, are apparent to patients and families. But falling into REM sleep quickly, a trait known as "short REM latency," isn’t obvious in everyday life. "You wouldn’t know you have it unless you were tested in a sleep laboratory," Giles says. "Your sense of time is mixed up when you sleep, so you can’t really remember how fast you fell asleep and started dreaming."

It takes the technology of a sleep laboratory to find short REM latency. Along with colleagues David Kupfer at the University of Pittsburgh, Howard Roffwarg at the University of Mississippi, and John Rush at the University of Texas Southwestern Medical Center in Dallas, Giles has studied the sleep patterns of 352 people in 70 families; in some families depression has affected at least one person, and in other families there is no history of depression. The brain activity, muscle activity, and eye movements of research subjects are monitored while they sleep for three nights; participants are also interviewed by phone at least once per year. Giles is currently expanding the study to include additional family members.

Among depressed people, about 30 to 40 percent of outpatients and 60 to 70 percent of depressed patients in the hospital have short REM latency, while approximately 20 percent of people who are not depressed have it. Since not all depressed people have short REM latency, and many healthy people do, the trait cannot be used to diagnose depression. But in families where depression has been identified, it might provide a way for some family members to find out if they are especially vulnerable.

"With this information, a person might be able to take some protective measures, such as becoming more educated about the first symptoms of depression," she says. Since it may not be practical to run all relatives of a depressed person through a sleep laboratory, Giles says an alternative would be to monitor the sleep patterns of a depressed person for two or three nights. If that person has short REM latency, his or her relatives are four times as likely to share the sleep pattern and the increased likelihood of depression.

Giles and several colleagues hope to use their work as a basis to launch a large multi-site trial on the genetics of depression. In the meantime, in the latest phase of the current study, Giles and colleague Michael Perlis, Ph.D., are testing whether Aricept, the same medicine used by patients with Alzheimer’s disease to stave off problems with memory, can change sleep patterns. Aricept boosts the amount of the brain chemical acetylcholine, which triggers REM sleep and improves memory.

Scientists will give research participants a small dose of the medicine and will monitor their sleep experiences, checking out the hypothesis that those with a tendency to enter dream sleep quickly are more sensitive to acetylcholine. If so, that would suggest that the chemical may play a fundamental role in somehow predisposing people to depression.


Story Source:

The above story is based on materials provided by University Of Rochester. Note: Materials may be edited for content and length.


Cite This Page:

University Of Rochester. "For Some, Sleep Style Serves As Harbinger Of Depression." ScienceDaily. ScienceDaily, 18 April 2001. <www.sciencedaily.com/releases/2001/04/010413083145.htm>.
University Of Rochester. (2001, April 18). For Some, Sleep Style Serves As Harbinger Of Depression. ScienceDaily. Retrieved July 23, 2014 from www.sciencedaily.com/releases/2001/04/010413083145.htm
University Of Rochester. "For Some, Sleep Style Serves As Harbinger Of Depression." ScienceDaily. www.sciencedaily.com/releases/2001/04/010413083145.htm (accessed July 23, 2014).

Share This




More Health & Medicine News

Wednesday, July 23, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins